Fiera Capital (Canada)’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53.9M Sell
1,445,885
-1,081,191
-43% -$33.1M 0.2% 78
2026
Q1
$84.2M Buy
2,527,076
+89,814
+4% +$3.01M 0.29% 64
2025
Q4
$84.3M Buy
2,437,262
+599,295
+33% +$19.1M 0.27% 63
2025
Q3
$50M Buy
1,837,967
+305,698
+20% +$7.39M 0.16% 92
2025
Q2
$32.2M Buy
1,532,269
+322,404
+27% +$6.19M 0.11% 132
2025
Q1
$19.8M Buy
1,209,865
+25,398
+2% +$541K 0.07% 151
2024
Q4
$30.4M Sell
1,184,467
-105,353
-8% -$2.98M 0.1% 129
2024
Q3
$40.9M Sell
1,289,820
-45,590
-3% -$1.73M 0.12% 114
2024
Q2
$46.9M Buy
1,335,410
+246,010
+23% +$9.74M 0.15% 103
2024
Q1
$47.8M Buy
+1,089,400
New +$46.8M 0.14% 104

Other funds holding IDYA

Fiera Capital (Canada)'s IDYA Position: Q2 2026 in Review

Fiera Capital (Canada) reduced its IDEAYA Biosciences (IDYA) stake by 43% in Q2 2026, selling an estimated $33.1M and leaving 1,445,885 shares worth $53.9M. The position accounts for 0.2% of the portfolio, ranked #78.

Fiera Capital (Canada) first reported a position in IDYA in Q1 2024 and has held it in 10 quarters since. The position peaked at $84.3M in Q4 2025. 284 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Fiera Capital (Canada) held 1,445,885 shares of IDEAYA Biosciences worth $53.9M as of Q2 2026.
  • Fiera Capital (Canada) sold 1,081,191 IDEAYA Biosciences shares in Q2 2026, an estimated $33.1M.
  • IDEAYA Biosciences made up 0.2% of Fiera Capital (Canada)'s portfolio in Q2 2026, its #78 holding.
  • Fiera Capital (Canada) first reported a position in IDEAYA Biosciences in Q1 2024 and has held it in 10 quarters since.
  • Fiera Capital (Canada)'s IDEAYA Biosciences position peaked at $84.3M in Q4 2025.
  • 284 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Fiera Capital (Canada)'s 13F filing for Q2 2026, filed 7 Aug 2026.